| Sagong, Min |
PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy |
|
|
| Recruiting | 3 | 160 | RoW | Brolucizumab 6mg, Beovu | Novartis Pharmaceuticals | Macular Polypoidal Choroidal Vasculopathy (PCV) | 09/25 | 09/25 | | |
EB-203-201, NCT06487039: Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration |
|
|
| Recruiting | 2 | 50 | RoW | EB-203 | EyebioKorea, Inc. | Neovascular Age-related Macular Degeneration (nAMD) | 08/25 | 01/26 | | |
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema |
|
|
| Recruiting | 2 | 150 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Diabetic Macular Edema (DME) | 11/25 | 12/25 | | |
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration |
|
|
| Recruiting | 2 | 180 | Japan, US, RoW | KHK4951, Aflibercept Injection | Kyowa Kirin Co., Ltd. | Neovascular Age-Related Macular Degeneration (nAMD) | 11/25 | 12/25 | | |
PMC403-A01, NCT05953012: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration |
|
|
| Recruiting | 1 | 36 | RoW | PMC-403, Monotherapy | PharmAbcine, C&R Research, Inc. | Neovascular Age-related Macular Degeneration | 05/24 | 10/25 | | |
| Park, Jung Tak |
NCT05257824: Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling |
|
|
| Recruiting | 4 | 528 | RoW | Aspirin 100mg, Aspirin protect, Aspirin enteric coated, Clopidogrel 75mg, Plavix, Celavix, Plavitor, Pregrel, Cloart, Platless, Pidogle, Antipla, Jgrel | Seoul National University Bundang Hospital, Soonchunhyang University Hospital, Seoul National University Hospital, Pusan National University Yangsan Hospital, Keimyung University Dongsan Medical Center, Seoul St. Mary's Hospital, Uijeongbu St. Mary's Hospital, Chungnam National University Sejong Hospital, Severance Hospital, Asan Medical Center, Yonsei University Gangnam Severance Hospital | Aneurysm Cerebral, Endovascular Procedures | 10/24 | 12/24 | | |
NCT06493799: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop |
|
|
| Not yet recruiting | 3 | 226 | NA | LAENNEC (Human Placenta Hydrolysate) IV, LAENNEC (Human Placenta Hydrolysate) SC | Green Cross Wellbeing | Chronic Liver Disease | 12/25 | 12/25 | | |
NCT05532124: Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups. |
|
|
| Recruiting | 2 | 49 | RoW | LAENNEC (Human Placenta Hydrolysate), normal saline | Green Cross Wellbeing | Chronic Liver Disease | 03/23 | 06/23 | | |
NCT03874793: Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) |
|
|
| Completed | N/A | 89 | US | Mindfulness-Based Cognitive Therapy, Muscle Relaxation Therapy | Ohio State University, National Center for Complementary and Integrative Health (NCCIH), University of Michigan | Post Traumatic Stress Disorder | 12/23 | 03/24 | | |
NCT04540939: Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for PTSD - COVID Related Substudy |
|
|
| Completed | N/A | 59 | US | Mindfulness-Based Cognitive Therapy, Muscle Relaxation Therapy | Ohio State University, National Center for Complementary and Integrative Health (NCCIH), University of Michigan | Trauma | 03/23 | 09/23 | | |
NCT05806346: Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery |
|
|
| Recruiting | N/A | 764 | RoW | TXA administration, Tranexamic acid, Placebo administration, Placebo (normal saline) | Konkuk University Medical Center, Korea Health Industry Development Institute, Helptrial, Asan Medical Center, Samsung Medical Center | Heart Diseases, Vascular Diseases, Transfusion Related Complication, Coagulation Disorder, Blood, Fibrinolysis; Hemorrhage | 04/25 | 06/25 | | |
NCT05830422: Prediction of Delayed Cognitive Impairment in Cardiac Arrest Survivors With Good Neurological Outcomes |
|
|
| Enrolling by invitation | N/A | 40 | RoW | nothing | Chungnam National University Hospital | Cardiac Arrest, Out-Of-Hospital, Cognitive Impairment | 03/27 | 09/27 | | |
| Recruiting | N/A | 3000 | RoW | Kidney Biopsy | Seoul National University Hospital, Chung-Ang University Hosptial, Chung-Ang University College of Medicine, KangWon National University Hospital, Keimyung University Dongsan Medical Center, SMG-SNU Boramae Medical Center, Seoul National University Bundang Hospital, Severance Hospital, Ministry of Health & Welfare, Korea | Glomerular Disease, Minimal Change Disease, IgA Nephropathy, Membranous Nephropathy, Focal Segmental Glomerulosclerosis, Lupus Nephritis, Crescentic Glomerulonephritis | 12/28 | 12/28 | | |
| Woo, SeJoon |
PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy |
|
|
| Recruiting | 3 | 160 | RoW | Brolucizumab 6mg, Beovu | Novartis Pharmaceuticals | Macular Polypoidal Choroidal Vasculopathy (PCV) | 09/25 | 09/25 | | |
PMC403-A01, NCT05953012: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration |
|
|
| Recruiting | 1 | 36 | RoW | PMC-403, Monotherapy | PharmAbcine, C&R Research, Inc. | Neovascular Age-related Macular Degeneration | 05/24 | 10/25 | | |
